Madox Remedies Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.00 M
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 5.60 M
- Revenue Growth -36.61%
- Profit Growth 28.74%
- Ebitda 648.03%
- Net Worth -28.99%
- Total Assets -29.73%
About Madox Remedies
Madox Remedies Private Limited (MRPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 February 2010 and has a history of 14 years and 11 months. Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹5.60 M.
Debasis Ghosh and Kazy Hossain serve as directors at the Company.
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51109WB2010PTC141753
- Company No.
141753
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Feb 2010
- Date of AGM
28 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Madox Remedies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Debasis Ghosh  | Director | 04-Feb-2010 | Current |
| Kazy Hossain | Director | 16-Mar-2020 | Current |
Financial Performance of Madox Remedies.
Madox Remedies Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 36.61% decrease. The company also saw a substantial improvement in profitability, with a 28.74% increase in profit. The company's net worth observed a substantial decline by a decrease of 28.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Madox Remedies?
In 2017, Madox Remedies had a promoter holding of 20.00% and a public holding of 80.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹5.60 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.56 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Oct 2010 | Others | ₹5.60 M | Open |
How Many Employees Work at Madox Remedies?
Madox Remedies has a workforce of 1 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Madox Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Madox Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
